Navigation Links
Week in Review in the Health Outcomes and Pharma Pricing Field from HealthEconomics.Com
Date:2/15/2013

Ponte Vedra Beach, Florida (PRWEB) February 15, 2013

The top news story available on HealthEconomics.Com explored results of a study by the European Consortium in Healthcare Outcomes (ECHOUTCOME) claiming that the QALY (quality-adjusted life years) has failed as a common metric for assessing cost-benefit of drug therapies. The findings have set off a controversial debate on the continued use of the QALY as a measure for deciding whether or not a drug will be reimbursed by payers or health systems. The QALY is used by NICE (the National Institute for Health and Clinical Excellence) for coverage decisions by the National Health Service in the United Kingdom, as well as by Canada and Australia. Generally if a treatment costs more than £20,000-30,000 per QALY, it would not be recommended as cost-effective by NICE.

The study findings caused a backlash of protests by UK-based experts, defending the current system and NICE called the study "limited". More details on the QALY debate can be found on HealthEconomics.Com News.

Another popular news story related to the Pharmacy Benefit Management (PBM) sector. Costco, the largest warehouse club chain in the United States, has entered into the PBM marketplace with the intent to offer services to small and medium-sized companies located near their warehouse stores. Currently, Express Scripts Holding and CVS Caremark dominate the PBM business. PBMs play a significant role in drug coverage decisions and can dramatically impact the success or failure of a pharmaceutical drug product’s success in the marketplace. For more on the impact of Costco on the PBM marketplace, visit the HealthEconomics.Com News portal.

Can the pharmaceutical industry’s reputation be fixed? John LaMattina, a contributing author to Forbes.Com, provides several suggestions for improving pharma’s image, including greater transparency with doctor payments and clinical trial data, improved marketing and detailing of drugs within established guidelines and regulations, as well as limiting television direct-to-consumer advertisements.

About HealthEconomics.Com (http://www.healtheconomics.com): A pioneer in the field, HealthEconomics.Com is the global authority in healthcare value and pharma market access. Each day, HealthEconomics.Com compiles the latest news, policy updates, resources, conferences, and jobs for BioPharma’s professionals involved in health economics, outcomes research, market access, and pricing. A trusted resource, HealthEconomics.Com’s comprehensive content is carefully selected by a discerning health economist editor, making it the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.

News Media interested in receiving the most current information on healthcare value and market access may obtain a free subscription to HealthEconomics.Com by visiting the site or by subscribing to the HealthEconomics.Com Newsletter.

Read the full story at http://www.prweb.com/releases/HealthEconomicsCom/News/prweb10426502.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Up to the Challenge: Careers in Science in the Midst of Drastic Change, According to Wysebridge Patent Bar Review
2. Sigma-Aldrich Corporation Will Hold Its Annual Business Review March 21, 2013
3. University of Colorado Cancer Center Review Shows Long-term Side-effects of New, Targeted Therapies in Pediatric Cancer Patients
4. Wysebridge Patent Bar Review Discusses Major Changes To The Patent Bar Exam
5. New EMR Comparison Website Launches Crowdsourcing Electronic Medical Record Software Reviews and Comparisons
6. Independent Marketing Automation Software Expert gives Positive review on MindMatrix's platform, AMP
7. Global Metabolomics Market Reviewed & Forecast in New In-Demand Report Available at MarketPublishers.com
8. Antigen Express AE37 Breast Cancer Vaccine Featured In "Micro-Cap Review" Interview
9. Wysebridge Patent Bar Review Announces the Launch of News Blog
10. Review Module Headlines BSI 8.6 Release for Enterprise Biobank Software
11. The 2013 CES: Patents, Legislation Reform, and the Growing Market for Patent Attorneys and Agents Reviewed by Wysebridge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... WEST LAFAYETTE, Indiana (PRWEB) , ... ... ... a division of Albany Molecular Research Inc. has further extended its industry ... sector. This service offers state-of-the-art cGMP techniques and methods for the ...
(Date:2/15/2017)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial ... full year ended December 31, 2016. ... we continued to demonstrate strong growth in our ... said Mihael H. Polymeropoulos, M.D., Vanda,s President and ... 2017 milestones underscores Vanda,s commitment to bringing important ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):